Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
42
pubmed:dateCreated
1996-12-5
pubmed:abstractText
The 42-residues beta-(1-42) peptide is the major protein component of amyloid plaque cores in Alzheimer's disease. In aqueous solution at physiological pH, the synthetic beta-(1-42) peptide readily aggregates and precipitates as oligomeric beta-sheet structures, a process that occurs during amyloid formation in Alzheimer's disease. Using circular dichroism (CD) and ultraviolet spectroscopic techniques, we show that nicotine, a major component in cigarette smoke, inhibits amyloid formation by the beta-(1-42) peptide. The related compound cotinine, the major metabolite of nicotine in humans, also slows down amyloid formation, but to a lesser extent than nicotine. In contrast, control substances pyridine and N-methylpyrrolidine accelerate the aggregation process. Nuclear magnetic resonance (NMR) studies demonstrate that nicotine binds to the 1-28 peptide region when folded in an alpha-helical conformation. On the basis of chemical shift data, the binding primarily involves the N-CH3 and 5'CH2 pyrrolidine moieties of nicotine and the histidine residues of the peptide. The binding is in fast exchange, as shown by single averaged NMR peaks and the lack of nuclear Overhauser enhancement data between nicotine and the peptide in two-dimensional NOESY spectra. A mechanism is proposed, whereby nicotine retards amyloidosis by preventing an alpha-helix-->beta-sheet conformational transformation that is important in the pathogenesis of Alzheimer's disease.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0006-2960
pubmed:author
pubmed:issnType
Print
pubmed:day
22
pubmed:volume
35
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
13568-78
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:8885836-Alzheimer Disease, pubmed-meshheading:8885836-Amino Acid Sequence, pubmed-meshheading:8885836-Amyloid beta-Peptides, pubmed-meshheading:8885836-Amyloidosis, pubmed-meshheading:8885836-Chemical Precipitation, pubmed-meshheading:8885836-Circular Dichroism, pubmed-meshheading:8885836-Cotinine, pubmed-meshheading:8885836-Humans, pubmed-meshheading:8885836-Magnetic Resonance Spectroscopy, pubmed-meshheading:8885836-Molecular Sequence Data, pubmed-meshheading:8885836-Molecular Structure, pubmed-meshheading:8885836-Nicotine, pubmed-meshheading:8885836-Peptide Fragments, pubmed-meshheading:8885836-Protein Binding, pubmed-meshheading:8885836-Protein Structure, Secondary, pubmed-meshheading:8885836-Pyridines, pubmed-meshheading:8885836-Pyrrolidines, pubmed-meshheading:8885836-Spectrophotometry, Ultraviolet
pubmed:year
1996
pubmed:articleTitle
Nicotine inhibits amyloid formation by the beta-peptide.
pubmed:affiliation
Department of Chemistry, School of Medicine, Case Western Reserve University, Cleveland, Ohio 44106, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't